INSMED INC's ticker is INSM and the CUSIP is 457669307. A total of 228 filers reported holding INSMED INC in Q1 2023. The put-call ratio across all filers is 0.82 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2022 | $116 | -99.9% | 5,790 | -32.9% | 0.08% | -84.0% |
Q3 2022 | $186,000 | +431.4% | 8,631 | +374.0% | 0.49% | +420.2% |
Q2 2022 | $35,000 | -62.8% | 1,821 | -54.8% | 0.09% | +10.6% |
Q1 2022 | $94,000 | +422.2% | 4,026 | +494.7% | 0.08% | +226.9% |
Q4 2021 | $18,000 | +38.5% | 677 | +48.5% | 0.03% | +73.3% |
Q3 2021 | $13,000 | -72.3% | 456 | -72.6% | 0.02% | -68.1% |
Q2 2021 | $47,000 | +261.5% | 1,667 | +265.6% | 0.05% | +840.0% |
Q2 2020 | $13,000 | – | 456 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Palo Alto Investors LP | 5,889,491 | $148,709,648 | 14.07% |
Deep Track Capital, LP | 6,000,000 | $151,500,000 | 5.85% |
Octagon Capital Advisors LP | 1,284,000 | $32,421,000 | 4.98% |
SUVRETTA CAPITAL MANAGEMENT, LLC | 3,446,334 | $87,019,934 | 4.70% |
MPM BioImpact LLC | 527,458 | $13,318,315 | 3.56% |
Novo Holdings A/S | 1,339,304 | $33,817,426 | 2.50% |
Bleichroeder LP | 325,000 | $8,206,250 | 2.02% |
GREAT POINT PARTNERS LLC | 394,872 | $9,970,518 | 1.82% |
Endurant Capital Management LP | 79,471 | $2,006,643 | 1.80% |
SECTORAL ASSET MANAGEMENT INC | 347,392 | $8,771,648 | 1.71% |